Catherine Kunst

Current

Executive Director at Bard Center for Entrepreneurship | Business School | University of Colorado Denver
Co-founder at Beacon Biotechnology, LLC
Research Assistant Professor at University of Denver

see less...

Past

Interim Director at Eleanor Roosevelt Institute
Scientist at Eleanor Roosevelt Institute

Education

University of Colorado at Denver
Emory University
Case Western Reserve University

see less...

Connections

237 connections

Industry

Higher Education

Websites

Catherine Kunst’s Summary

I am the executive director for the Bard Center for Entrepreneurship at the University of Colorado Denver. I'm a scientist by training who still runs a biomedical research lab focused on ALS (Lou Gehrig's disease). I am also involved with a biotech startup.

Catherine Kunst’s Specialties:

genetic modifiers, molecular genetics, neurodegeneration, business development, entrepreneurship, fund raising

Catherine Kunst’s Experience

Executive Director

Bard Center for Entrepreneurship | Business School | University of Colorado Denver

(Educational Institution; Higher Education industry)

January 2008 — Present (1 year 11 months)
Co-founder

Beacon Biotechnology, LLC

(Privately Held; Biotechnology industry)

October 2006 — Present (3 years 2 months)

Beacon Biotechnology, LLC was formed in September, 2006 to develop a new generation of diagnostics that are highly mobile, simple, inexpensive and powerful. Beacon microarray technology will overcome limitations in existing technology allowing introduction of microarray technology into markets such as point-of-care and field applications that are currently difficult, or impossible, with the current microarray technology.
Research Assistant Professor

University of Denver

(Educational Institution; Research industry)

June 2003 — Present (6 years 6 months)

I work with a mouse model for ALS (amyotrophic lateral sclerosis; Lou Gehrig's disease) that carries a mutated gene like found in some people with ALS. My NIH funded research lab is actively seeking the genetic differences between mouse strains that naturally make some mice resistant to developing this fatal neurodegenerative disease.
Interim Director

Eleanor Roosevelt Institute

(Educational Institution; Research industry)

September 2005 — December 2007 (2 years 4 months)

This position reported to the Dean of the Division of Natural Sciences and Mathematics at the University of Denver and to the Eleanor Roosevelt Institute Board of Trustees. Responsibilities included fundraising, serving as a liasion to biotech and non-profit tenant companies, budget preparation and oversight, and overseeing research compliance pertaining to the use of animals, human subjects, hazardous materials, biohazards and radioactive materials.
Scientist

Eleanor Roosevelt Institute

(Non-Profit; 51-200 employees; Research industry)

June 1998 — June 2003 (5 years 1 month)

Catherine Kunst’s Education

University of Colorado at Denver

MBA , Entrepreneurship , 2004 — 2006
Emory University

Ph.D. , Biochemistry and Molecular Biology , 1988 — 1994
Case Western Reserve University

BS , Biochemistry , 1984 — 1988

Additional Information

Catherine Kunst’s Websites:

Catherine Kunst’s Interests:

higher education, biotechnology, entrepreneurship, personal development, fitness, bioscience entrepreneurship

Catherine Kunst’s Groups:

American Society of Human Genetics, ASHG, Beta Gamma Sigma, University of Colorado Denver, University of Colorado at Denver, Bard Center for Entrepreneurship, Eleanor Roosevelt Institute, ERI